Astellas Pharma Inc
TSE:4503

Watchlist Manager
Astellas Pharma Inc Logo
Astellas Pharma Inc
TSE:4503
Watchlist
Price: 1 519 JPY -1.52% Market Closed
Market Cap: 2.7T JPY
Have any thoughts about
Astellas Pharma Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Astellas Pharma Inc

Wall Street analysts forecast Astellas Pharma Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Astellas Pharma Inc is 1 990.36 JPY with a low forecast of 1 414 JPY and a high forecast of 2 520 JPY.

Lowest
Price Target
1 414 JPY
7% Downside
Average
Price Target
1 990.36 JPY
31% Upside
Highest
Price Target
2 520 JPY
66% Upside
Astellas Pharma Inc Competitors:
Price Targets
SUNPHARMA
Sun Pharmaceutical Industries Ltd
13% Upside
HIKAL
Hikal Ltd
21% Upside

Revenue
Forecast

Revenue Estimate
Astellas Pharma Inc

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's revenue is 2%. The projected CAGR for the next 3 years is 7%.

2%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Astellas Pharma Inc

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's operating income is -9%. The projected CAGR for the next 2 years is 88%.

-9%
Past Growth
88%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Astellas Pharma Inc

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's net income is -26%. The projected CAGR for the next 3 years is 131%.

-26%
Past Growth
131%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Astellas Pharma Inc's stock price target?
Price Target
1 990.36 JPY

According to Wall Street analysts, the average 1-year price target for Astellas Pharma Inc is 1 990.36 JPY with a low forecast of 1 414 JPY and a high forecast of 2 520 JPY.

What is Astellas Pharma Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's revenue is 2%. The projected CAGR for the next 3 years is 7%.

What is Astellas Pharma Inc's Operating Income forecast?
Projected CAGR
88%

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's operating income is -9%. The projected CAGR for the next 2 years is 88%.

What is Astellas Pharma Inc's Net Income forecast?
Projected CAGR
131%

For the last 8 years the compound annual growth rate for Astellas Pharma Inc's net income is -26%. The projected CAGR for the next 3 years is 131%.

Back to Top